• 沒有找到結果。

臺中榮總兒科常用水劑藥品

N/A
N/A
Protected

Academic year: 2022

Share "臺中榮總兒科常用水劑藥品"

Copied!
4
0
0

加載中.... (立即查看全文)

全文

(1)

臺中榮總兒科常用水劑藥品

1

藥品成份/商品名 成 份 含 量 一 般 劑 量 Analgesics/Antipyretics (止痛退燒藥)

* Acetaminophen Anti-phen® syrup 安佳熱糖漿

24 mg/ml, 60ml/bot Fever: 10-15 mg/kg/dose PO Q4H-Q6H, maximum 5 doses/day

Ibuprofen

Ibuprofen oral ® susp 依普芬口服懸液劑

20 mg/ml, 60 ml/bot 6 m/o-12 yrs: 0.25-0.5 ml/kg

Epectorants (袪痰劑)

Ambroxol

Soltan® sol'n 100mL 舒痰液

3 mg/ml, 100 ml/bot

< 2 yrs: 1.2-1.6 mg/kg/day (分2次服用)

2-5 yrs: 2.5 ml BID

Mucolytic Drugs (黏液溶解劑)

* Bromhexine Bisolvon® solution

氣舒痰液

2 mg/ml, 50 ml/bot

Infant : 0.5ml TID 5 yrs : 1ml TID 5-10 yrs: 2 ml TID

Antitussives (鎮咳劑)

Butamirate citrate Sutussi® liquid

停咳喜液

0.8 mg/mL, 120 mL/bot

Adults:20-25 mg QID

≧12 years:15-22 mg QID

6-12 years:6-15 mg (7.5-15 ml) QID 3-6 years:5-6 mg (7.5 ml) QID 1-3 years:3 mg (3.75 mL) QID 2 month-1 years:2 mg (2.5 ml) QID

Antihistamines (抗組織胺藥)

* Cetirizine HCl Cetirizine® Sol'n 勝克敏液

1 mg/ml, 60 ml/bot

3-6 y/o: 5 ml/day QD~BID

>6 y/o: 10 ml QD

* Cyproheptadine HCl Cyproh® syrup 喜普液

0.4 mg /ml, 60 ml/bot

2-6 yrs: 5 ml TID 6-14yrs : 10 ml TID

Ketotifen Athmin® syrup 喘敏糖漿

0.2 mg/ml, 60ml/bot 0.5-2 mg BID

* Loratadin Clatine® syrup 宜敏靜糖漿

1 mg/ml, 60 ml/bot 2-12 yrs:≦30 kg: 5 mg QD >30 kg: 10 mg QD

Autonomic-β-Adrenergic Agonists

* Procaterol Meptin® Liquid 滅喘淨液

5 mcg/ml, 60 ml/bot < 6 y/o: 10-15 mcg QD

> 6 y/o: 25 mcg QD-BID

(2)

臺中榮總兒科常用水劑藥品

2

藥品成份/商品名 成 份 含 量 一 般 劑 量 Respir. Smooth Muscle Relax. (呼吸系統平滑肌鬆弛劑)

* Theophylline Centertheo® liquid 適優喘液

5.34 mg/ml, 60 ml/bot

6-12 yrs: 125-250 mg Q6H (3 ml/kg/day Q8-6H or 1 ml/kg/dose)

Misc. Respiratory Tract Agents (其他呼吸道治療劑)

Chlorpheniramine +

Methylephedrine + guaiacoL Secorine® syrup

息咳寧糖漿

Each ml:

Chlorpheniramine 0.1mg + Methylephedrine 1mg + guaiacol glycolate 5 mg.

120mL/bot

Adult:20 mL 3~4 times a day.

9-12 yrs: 10 mL 3~4 times a day.

6-9 yrs: 6.7 mL 3~4 times a day.

Antibacterials (抗生素)

* Amoxicillin Amolin® oral susp 萬博黴懸液用粉

50 mg/ml, 60 ml/bot

 20-40 mg/kg/day, 分3~4次服用

 須先加水至藥瓶上60ml之刻度,並充分 振搖溶解,每次使用前也需搖勻。

 稀釋後需冷藏,安定性為7天。

* Amoxicillin+Potassium clavulanate

Curam® oral syrup 諾快寧口服懸液用粉

Each 5ml:

Amoxicillin 250 mg + Potassium clavulanate 62.5mg

60 ml/bot

 2-12 yrs: 30~60mg/kg/day Q8H

< 2 yrs: 30~40mg/kg/day Q8H (Amoxicillin dose)

 須先加水至瓶身凹陷標記處,並充分振 搖溶解,每次使用前也需搖勻。

 稀釋後需冷藏,安定性為7天。

* Azithromycin Zithromax® susp 日舒懸液用粉

200 mg/5 ml, 15 ml/bot

 <15 kg: 10 mg/kg for 3 days

15-25 kg: 200mg (5ml)/QD for 3day

 須先加9ml水,稀釋後為15ml,並充分 振搖溶解,每次使用前也需搖勻。

 稀釋後室溫安定性為5天。

* Clarithromycin Klaricid ®susp

開羅理黴素懸液劑

125mg/5mL,70mL

 Infants ≥1 months,Children: 7.5 mg/kg Q12H (MAX:500mg/dose) for non- mycobacterial infections for 10 days.

 children with disseminated or localized mycobacterial infections: 7.5 to 15 mg/kg Q12H

* Trimethoprin+

Sulfamethoxazole SulfacoTrim® syr 沙法克寧懸液劑

Each 5ml:

Trimethoprin 40mg + Sulfamethoxazole 200mg

60ml/bot

6-10 mg TMP/kg/day, Q12H

(3)

臺中榮總兒科常用水劑藥品

3

藥品成份/商品名 成 份 含 量 一 般 劑 量 Antifungals(抗黴菌)

*Nystatin

Mycostatin® susp 滅菌靈懸液用粉劑

100,000 U/ml, 24 ml/bot

 1 ml QID (需要時可增加劑量)

 須先加23ml水稀釋,並充分振搖溶解,

每次使用前也需搖勻。

 稀釋後室溫安定性為7天。

Posaconazole Posanol® susp 波賽特口服懸液劑

40 mg/ml, 105 ml/bot > 13 yrs : 200mg TID

Anticonvulsants (抗痙攣劑)

* Levetiracetam

Keppra ® oral solution 優閒內服液劑

100 mg/ml, 300 ml/bottle

4-15 years: 10 mg/kg/dose BID, may increase every 2 weeks by 10 mg/kg/dose to a

maximum of 30 mg/kg/dose BID.

*Oxcarbazepine Trileptal® susp

除癲達口服懸浮液

60 mg/ml, 100 ml/bot 4-16 yrs:

起始劑量: 8-10 mg/kg/day分2次 服用

* Valproate Sod.

Depakine® solution 帝拔癲液

200 mg/ml, 40 ml/bot 20-30 mg/kg/day, BID - TID

Misc. Anoxiolytic, Sedatives, Hypnotics (其它鎮靜安眠劑)

Chloral hydrate 10% solution 2 mg/ml Sedation: 25 mg/kg/day, Q8H Hypnotic: 50 mg/kg/dose

Antiflatulents (脹氣治療劑)

* Simethicone Wilcon® susp

胃爾康懸浮液

20 mg/ml, 60 ml/bot < 2 yrs : 1ml QID

> 2 yrs : 2ml QID

GI Prokinetic Drugs (腸胃蠕動劑)

* Domperidone Wempty® susp

胃利空懸液劑

1 mg/ml, 60 ml/bot 0.25-0.5 ml/kg/dose TID-QID, before meal

Cariotonic Drugs (強心劑)

* Digoxin

Cardiacin® elixir 地高新酏劑

50 mcg/ml, 60 ml/bot 10-20 mcg/kg/day

Diuretics(利尿劑)

* Furosemide

Fumide® oral solution 福滿內服液劑

10 mg/ml, 120 ml/bot

 早產新生兒(<29 週):

1-2 mg/kg/dose Q24H

 早產新生兒(>29 週):

1-2 mg/kg/dose Q12- 24H

 新生兒: 1-3 mg/kg Q8H(需要時)

 嬰兒及小孩:起始劑量: 2 mg/kg/dose, 1-2 mg/kg/dose Q6-8H,MAX: 6mg/kg/dose

(4)

臺中榮總兒科常用水劑藥品

4

藥品成份/商品名 成 份 含 量 一 般 劑 量 Hormones & Synthetic substitutes- Adrenals(腎上腺素)

* Prednisolone

Kidsolone® oral susp 必爾生口服液

1 mg/ml, 60 ml/bot 遵照醫囑

Immunosuppressive Agents

* Cyclosporin

Sandimmun® sol'n 新體睦口服溶液

100mg/ml, 50 ml/Bot

依各疾病適量投與,必要時依血中濃度調 整劑量

Iron Preparations (鐵製劑)

* Ferrum Hausmann® 富鐵好滴劑

50 mg iron /ml (1drop = 2.5 mg iron)

30 ml/bot

Infants: Begin with 6 drops daily and gradually increase to 20 drops daily

Children: 20 drops 1-2 times daily

Replacement Preparations (取代用藥)

Neutral Phosphate solution powder/pack

Phosphorus: 200 mg/10ml Sodium: 1.08 mEq/ml

500 ml/bot

視需要適量投與

 *有此星號標示之水劑為本院另有口服錠劑或膠囊劑型,因此對於較小的幼兒病患,請醫師們儘量開立水劑 藥品。

 滑鼠點選藥理分類標題即可超連結藥品手冊查詢系統。

藥學部 2017-03更新

參考文獻

相關文件

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). J Eur Acad Dermatol

Effect of duloxetine on pain function, and quality of life among patients with chemotherapy-induced peripheral neuropathy: a randomized

Roflumilast - a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD.. Swiss

在中度腎功能不全者 (CrCl 30-50 mL/min),與 dronedarone 或 ketoconazole 併用時,dabigatran 應降低 劑量至 75 mg bid。而與 verapamil, amiodarone, quinidine, 和

1.Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R.. PCSK9 inhibitors: Pharmacology,

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for

ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production, Second Revision 2018. Modeling drug passage into

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after longterm continued, discontinued, and restarting of therapy: a randomized